Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm Dermis

Inclusion Criteria: * Age 35 to 50 years * Male or Female * Good general health status * Able to give informed consent Exclusion Criteria: * Clinically significant abnormalities of haematology or biochemistry testing * Bleeding diathesis * anticoagulant drugs * thrombocytopenia or clinically significant prolonged APTT or PT * Chronic use of aspirin, other non-steroidal anti-inflammatory drugs or other anti-platelet agents * History of keloid formation * Systemic corticosteroids within last 12 weeks * Diabetes or other metabolic disorders that may interfere with the subject's response to treatment in the opinion of the investigator * Any serious medical condition which in the opinion of the investigator would have a strong possibility of requiring systemic corticosteroid medication * Pregnancy/lactation * Previously received Tropoelastin * A history of anaphylaxis or allergic reactions including any known hypersensitivity to Hyaluronic acid or lidocaine * Sensitivity to Restylane® Vital light or Restylane products * Use of any other investigational product on the intended implant site in the previous 12 months. * Sensitivity to topical local anaesthetic cream (EMLA®) or have the following conditions where EMLA is contraindicated: dermatitis, Methaemoglobinaemia, Glucose-6-phosphate dehydrogenase deficiency or "Mollusca Contagiosa"